谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

845P Vidutolimod + pembrolizumab as 2L+ treatment in patients with anti–PD-1–refractory melanoma and adrenal insufficiency: Subgroup analyses of a phase Ib study

J.M. Kirkwood,Y. Zakharia,D. Davar,E. Buchbinder,T. Medina,A. Daud,A. Ribas,B. Chmielowski,J.J. Niu,G.T. Gibney,K.A. Margolin,A.J. Olszanski,I. Mehmi, T. Sato, M. Shaheen, L. Zhao,D. Bobilev, A.M. Krieg, J. Wooldridge,M. Milhem

Annals of Oncology（2022）

引用 0|浏览6
暂无评分
关键词
anti–pd-1–refractory melanoma,adrenal insufficiency,treatment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要